Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,1.0841446446991207e-05,13.969465648854962,159.70080508898513,"['CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'HES5']",0.002200813628739215,0,0,6
2,The influence of laminopathies on Wnt signaling WP4844,0.00022752929393977456,15.57502451781628,130.6469122593976,"['CEBPD', 'HMGA2', 'HES1', 'HES5']",0.02309422333488712,0,0,4
3,Globo Sphingolipid Metabolism WP1424,0.0008655433498794615,19.06183368869936,134.42696950296994,"['ST6GAL1', 'ST6GAL2', 'FUT2']",0.0471437415830417,0,0,3
4,Differentiation Pathway WP2848,0.0010300642215391204,17.78955223880597,122.3589263697971,"['EGF', 'HGF', 'WNT7B']",0.0471437415830417,0,0,3
5,Genotoxicity pathway WP4286,0.0011611759010601403,9.670392196707986,65.35562510051534,"['ARRDC4', 'ACTA2', 'ITPKC', 'CEBPD']",0.0471437415830417,0,0,4
6,Adipogenesis WP236,0.002502314192260947,5.757575757575758,34.490983839147525,"['SOCS3', 'KLF6', 'CEBPD', 'ID3', 'IRS2']",0.08466163017149538,0,0,5
7,Apoptosis Modulation and Signaling WP1772,0.005025716711020506,6.266719430154334,33.17091911221669,"['IL1R1', 'TNFRSF11B', 'MAP3K14', 'HSPA1A']",0.14305681691011266,0,0,4
8,Vitamin D Receptor Pathway WP2877,0.005637707070349268,6.053268765133172,31.34550752993674,"['BCL6', 'TNFRSF11B', 'PRKCQ', 'ATP2C2']",0.14305681691011266,0,0,4
9,Leptin Insulin Overlap WP3935,0.006576775438121976,19.62962962962963,98.62339539413391,"['SOCS3', 'IRS2']",0.14834282377097346,0,0,2
10,Transcription factor regulation in adipogenesis WP3599,0.009189649298290862,16.057912457912458,75.30643082427926,"['CEBPD', 'IRS2']",0.16959080068664045,0,0,2
11,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.009189649298290862,16.057912457912458,75.30643082427926,"['EGF', 'HSPB1']",0.16959080068664045,0,0,2
12,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.015214213838550514,6.191079486289483,25.912919001541248,"['IL1R1', 'IRF7', 'MAP3K14']",0.22555576920003353,0,0,3
13,Complement and Coagulation Cascades WP558,0.015555570289657485,11.771851851851851,49.010180328690275,"['C1R', 'PROS1']",0.22555576920003353,0,0,2
14,Monoamine Transport WP727,0.015555570289657485,11.771851851851851,49.010180328690275,"['IL1R1', 'TNFRSF11B']",0.22555576920003353,0,0,2
15,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.017053942264757458,5.914925373134328,24.081872690609163,"['PLCE1', 'PRKCQ', 'IFI44L']",0.23079668531638425,0,0,3
16,MAPK Signaling Pathway WP382,0.020222290490490617,2.9574700109051255,11.537001177261281,"['EGF', 'IL1R1', 'HSPB1', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.2565703105980997,0,0,6
17,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.023321459642995652,9.290448343079921,34.91704757732441,"['HSPB1', 'NDRG1']",0.27207933360838227,0,0,2
18,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.025465553391917552,8.825185185185186,32.39221199289409,"['P3H2', 'TNFRSF11B']",0.27207933360838227,0,0,2
19,Lung fibrosis WP3624,0.025465553391917552,8.825185185185186,32.39221199289409,"['EGF', 'HGF']",0.27207933360838227,0,0,2
20,Breast cancer pathway WP4262,0.029639420620430224,3.595352016404648,12.650785465872845,"['EGF', 'WNT7B', 'HES1', 'HES5']",0.27665712277788057,0,0,4
21,Signal transduction through IL1R WP4496,0.02998254532568164,8.021548821548821,28.132693844590545,"['IL1R1', 'MAP3K14']",0.27665712277788057,0,0,2
22,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.02998254532568164,8.021548821548821,28.132693844590545,"['ACTA2', 'PRKCQ']",0.27665712277788057,0,0,2
23,Myometrial relaxation and contraction pathways WP289,0.03343285559859348,3.454558726914373,11.739337298237343,"['ACTA2', 'RGS17', 'GRK5', 'PRKCQ']",0.2950812907180207,0,0,4
24,IL17 signaling pathway WP2112,0.037300634042618894,7.057185185185185,23.20928216732865,"['CEBPD', 'MAP3K14']",0.3155011962771515,0,0,2
25,Osteoblast Signaling WP322,0.044636252772266766,29.24264705882353,90.92149872019996,['TNFRSF11B'],0.32484363177155173,0,0,1
26,Wnt signaling pathway and pluripotency WP399,0.04514748439051578,3.9653597683225663,12.283973642182696,"['WNT7B', 'PRKCQ', 'CD44']",0.32484363177155173,0,0,3
27,Complement system WP2806,0.04522461612752237,6.2994708994709,19.503878380099092,"['C1R', 'PROS1']",0.32484363177155173,0,0,2
28,Osteoblast differentiation WP4787,0.048402291469474695,3.8497728747566513,11.657913487076454,"['WNT7B', 'SMAD9', 'PRKCQ']",0.32484363177155173,0,0,3
29,Nuclear Receptors Meta-Pathway WP2882,0.0552325612091286,2.5305612947658402,7.329018258629724,"['HGF', 'IRS2', 'HES1', 'SLC5A3', 'HSPA1A']",0.32484363177155173,0,0,5
30,Serotonin Transporter Activity WP1455,0.05548273648441745,21.93014705882353,63.41504135323051,['IL1R1'],0.32484363177155173,0,0,1
31,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.05548273648441745,21.93014705882353,63.41504135323051,['SMAD9'],0.32484363177155173,0,0,1
32,NAD Biosynthesis II (from tryptophan) WP2485,0.05548273648441745,21.93014705882353,63.41504135323051,['HAAO'],0.32484363177155173,0,0,1
33,PTF1A related regulatory pathway WP4147,0.05548273648441745,21.93014705882353,63.41504135323051,['HES1'],0.32484363177155173,0,0,1
34,ESC Pluripotency Pathways WP3931,0.0606672507317015,3.4931264728986644,9.788967348823427,"['EGF', 'WNT7B', 'SMAD9']",0.32484363177155173,0,0,3
35,Metapathway biotransformation Phase I and II WP702,0.06252754092314326,3.4474704400077534,9.556898852536477,"['CYP39A1', 'HS3ST3B1', 'CHST6']",0.32484363177155173,0,0,3
36,Notch Signaling WP268,0.0626989697573519,5.185185185185185,14.35990506626905,"['HES1', 'HES5']",0.32484363177155173,0,0,2
37,TGF-beta Receptor Signaling WP560,0.06580269843217067,5.0366137566137565,13.705101648673455,"['EGF', 'SMAD9']",0.32484363177155173,0,0,2
38,Transcriptional cascade regulating adipogenesis WP4211,0.06620696883015365,17.54264705882353,47.6277526304324,['CEBPD'],0.32484363177155173,0,0,1
39,Complement Activation WP545,0.06620696883015365,17.54264705882353,47.6277526304324,['C1R'],0.32484363177155173,0,0,1
40,Farnesoid X receptor pathway WP2879,0.06620696883015365,17.54264705882353,47.6277526304324,['IRS2'],0.32484363177155173,0,0,1
41,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.06620696883015365,17.54264705882353,47.6277526304324,['SOCS3'],0.32484363177155173,0,0,1
42,NRF2 pathway WP2884,0.06826574133886396,3.317350746268657,8.904921283975234,"['HGF', 'SLC5A3', 'HSPA1A']",0.32484363177155173,0,0,3
43,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.06895685655957479,4.896296296296296,13.09403904287566,"['PRKCQ', 'MAP3K14']",0.32484363177155173,0,0,2
44,Insulin Signaling WP481,0.07353728288329883,2.6285714285714286,6.860473517593209,"['SOCS3', 'IRS2', 'PRKCQ', 'MAP3K14']",0.32484363177155173,0,0,4
45,Modulators of TCR signaling and T cell activation WP5072,0.07541038849764055,4.637816764132554,11.987876239870843,"['PRKCQ', 'MAP3K14']",0.32484363177155173,0,0,2
46,Gene regulatory network modelling somitogenesis  WP2854,0.07681031687209104,14.617647058823529,37.51496787789796,['HES1'],0.32484363177155173,0,0,1
47,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.07681031687209104,14.617647058823529,37.51496787789796,['HES1'],0.32484363177155173,0,0,1
48,Osteoclast Signaling WP12,0.07681031687209104,14.617647058823529,37.51496787789796,['TNFRSF11B'],0.32484363177155173,0,0,1
49,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.07870679474753392,4.518518518518518,11.486190606485541,"['EGF', 'SMAD9']",0.326071006811212,0,0,2
50,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.0854316706855828,4.297380307136405,10.57172055698193,"['SOCS3', 'HSPB1']",0.32816127696201614,0,0,2
51,IL-4 signaling pathway WP395,0.0854316706855828,4.297380307136405,10.57172055698193,"['SOCS3', 'IRS2']",0.32816127696201614,0,0,2
52,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.08729413278792547,12.528361344537815,30.550058668577076,['PRKCQ'],0.32816127696201614,0,0,1
53,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.08729413278792547,12.528361344537815,30.550058668577076,['FAM20C'],0.32816127696201614,0,0,1
54,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.08729413278792547,12.528361344537815,30.550058668577076,['EGF'],0.32816127696201614,0,0,1
55,Interferon type I signaling pathways WP585,0.0958282771060261,4.0033670033670035,9.388686165525899,"['SOCS3', 'IRS2']",0.3370065550428562,0,0,2
56,IL1 and megakaryocytes in obesity WP2865,0.09765975392593837,10.961397058823529,25.499122441063626,['IL1R1'],0.3370065550428562,0,0,1
57,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.09765975392593837,10.961397058823529,25.499122441063626,['PRKCQ'],0.3370065550428562,0,0,1
58,Cardiac Hypertrophic Response WP2795,0.09937090443284868,3.9140740740740743,9.037189660642978,"['EGF', 'MAP3K14']",0.3370065550428562,0,0,2
59,IL-1 signaling pathway WP195,0.10656401466211157,3.7468873128447595,8.389315905834556,"['IL1R1', 'MAP3K14']",0.3370065550428562,0,0,2
60,Regulatory circuits of the STAT3 signaling pathway WP4538,0.10656401466211157,3.7468873128447595,8.389315905834556,"['SOCS3', 'OSMR']",0.3370065550428562,0,0,2
61,FOXA2 pathway WP5066,0.10790850284623474,9.742647058823529,21.6917270515378,['IRS2'],0.3370065550428562,0,0,1
62,Hypertrophy Model WP516,0.10790850284623474,9.742647058823529,21.6917270515378,['IL1R1'],0.3370065550428562,0,0,1
63,ID signaling pathway WP53,0.10790850284623474,9.742647058823529,21.6917270515378,['ID3'],0.3370065550428562,0,0,1
64,Kynurenine Pathway and links to Cellular Senescence WP5044,0.10790850284623474,9.742647058823529,21.6917270515378,['HAAO'],0.3370065550428562,0,0,1
65,Osteopontin Signaling WP1434,0.10790850284623474,9.742647058823529,21.6917270515378,['MAP3K14'],0.3370065550428562,0,0,1
66,Notch Signaling Pathway Netpath WP61,0.11021198767689466,3.6685185185185185,8.090365873389725,"['HES1', 'HES5']",0.3389853560365093,0,0,2
67,Tryptophan catabolism leading to NAD+ production WP4210,0.1180416875504491,8.76764705882353,18.73398431330442,['HAAO'],0.3423208938963024,0,0,1
68,Differentiation of white and brown adipocyte WP2895,0.1180416875504491,8.76764705882353,18.73398431330442,['SMAD9'],0.3423208938963024,0,0,1
69,GPR40 Pathway WP3958,0.1180416875504491,8.76764705882353,18.73398431330442,['PLCE1'],0.3423208938963024,0,0,1
70,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.1180416875504491,8.76764705882353,18.73398431330442,['MAP3K14'],0.3423208938963024,0,0,1
71,Oncostatin M Signaling Pathway WP2374,0.12134700900043527,3.4518518518518517,7.280304174722098,"['SOCS3', 'OSMR']",0.3457272533331761,0,0,2
72,IL-18 signaling pathway WP4754,0.12599415653762921,2.145181134654819,4.443785087317753,"['ACTA2', 'SOCS3', 'HSPB1', 'TNFRSF11B']",0.3457272533331761,0,0,4
73,Cysteine and methionine catabolism WP4504,0.12806060147587026,7.9699197860962565,16.380191014488815,['SQOR'],0.3457272533331761,0,0,1
74,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.12806060147587026,7.9699197860962565,16.380191014488815,['SYTL4'],0.3457272533331761,0,0,1
75,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.12943483376020387,2.4746129167247872,5.059538481445432,"['TRIP10', 'IRS2', 'MAP3K14']",0.3457272533331761,0,0,3
76,Calcium Regulation in the Cardiac Cell WP536,0.12943483376020387,2.4746129167247872,5.059538481445432,"['RGS17', 'GRK5', 'PRKCQ']",0.3457272533331761,0,0,3
77,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.13274425513723326,3.259259259259259,6.581522918989005,"['HSPA1B', 'HSPA1A']",0.3499621271799786,0,0,2
78,MECP2 and Associated Rett Syndrome WP3584,0.13659638521081519,3.1997306397306398,6.369783121132666,"['CEBPD', 'BCL6']",0.3545215738492399,0,0,2
79,Canonical and non-canonical TGF-B signaling WP3874,0.137966523813251,7.305147058823529,14.469627698439874,['LOXL2'],0.3545215738492399,0,0,1
80,Neural Crest Differentiation WP2064,0.1404732445160401,3.1423280423280424,6.167567407635567,"['HES1', 'HES5']",0.35645085795945175,0,0,2
81,T-cell receptor (TCR) signaling pathway WP69,0.14437378717827296,3.0869395711500975,5.974307258810863,"['PRKCQ', 'MAP3K14']",0.36182566416283224,0,0,2
82,ERK Pathway in Huntington's Disease WP3853,0.14776071945992672,6.742647058823529,12.893027241545148,['EGF'],0.3657978786629893,0,0,1
83,Prolactin Signaling Pathway WP2037,0.1562073584618616,2.9318518518518517,5.443190929345208,"['SOCS3', 'IRS2']",0.373266403011594,0,0,2
84,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.1574444393454652,6.260504201680672,11.57368549172362,['PRKCQ'],0.373266403011594,0,0,1
85,Apoptosis Modulation by HSP70 WP384,0.16701892050457112,5.8426470588235295,10.456282655039288,['HSPA1A'],0.373266403011594,0,0,1
86,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.17225703833657538,2.747685185185185,4.832539427985441,"['EGF', 'MAP3K14']",0.373266403011594,0,0,2
87,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.17432109553350347,1.8790593505039195,3.2824466715554186,"['EGF', 'HGF', 'IRS2', 'OSMR']",0.373266403011594,0,0,4
88,Canonical and non-canonical Notch signaling WP3845,0.17648538619552578,5.477022058823529,9.49998898659834,['HES1'],0.373266403011594,0,0,1
89,Kallmann's Syndrome WP5074,0.17648538619552578,5.477022058823529,9.49998898659834,['PRKCQ'],0.373266403011594,0,0,1
90,Spinal Cord Injury WP2431,0.18446577638690176,2.623991155334439,4.435309490794158,"['ZFP36', 'IL1R1']",0.373266403011594,0,0,2
91,Striated Muscle Contraction Pathway WP383,0.18584504612421723,5.154411764705882,8.674060797938033,['ACTA2'],0.373266403011594,0,0,1
92,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.18584504612421723,5.154411764705882,8.674060797938033,['IRF7'],0.373266403011594,0,0,1
93,White fat cell differentiation WP4149,0.18584504612421723,5.154411764705882,8.674060797938033,['CEBPD'],0.373266403011594,0,0,1
94,Ebstein-Barr virus LMP1 signaling WP262,0.18584504612421723,5.154411764705882,8.674060797938033,['MAP3K14'],0.373266403011594,0,0,1
95,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.18584504612421723,5.154411764705882,8.674060797938033,['BCL6'],0.373266403011594,0,0,1
96,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.18584504612421723,5.154411764705882,8.674060797938033,['UGCG'],0.373266403011594,0,0,1
97,Ovarian infertility WP34,0.18584504612421723,5.154411764705882,8.674060797938033,['SYNE2'],0.373266403011594,0,0,1
98,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.18856337457505898,2.585185185185185,4.312919053782458,"['EGF', 'HGF']",0.373266403011594,0,0,2
99,Hippo-Yap signaling pathway WP4537,0.19509909651452295,4.867647058823529,7.954940826529918,['NDRG1'],0.373266403011594,0,0,1
100,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.19509909651452295,4.867647058823529,7.954940826529918,['ATP2C2'],0.373266403011594,0,0,1
101,Senescence and Autophagy in Cancer WP615,0.2009287001423393,2.4753260302556077,3.9724159848312643,"['IRF7', 'CD44']",0.373266403011594,0,0,2
102,Sphingolipid Metabolism (general overview) WP4725,0.20424872035632863,4.611068111455109,7.324298101890035,['UGCG'],0.373266403011594,0,0,1
103,Toll-like Receptor Signaling related to MyD88 WP3858,0.20424872035632863,4.611068111455109,7.324298101890035,['IRF7'],0.373266403011594,0,0,1
104,Vitamin B12 metabolism WP1533,0.20424872035632863,4.611068111455109,7.324298101890035,['SERPINA3'],0.373266403011594,0,0,1
105,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.20424872035632863,4.611068111455109,7.324298101890035,['HGF'],0.373266403011594,0,0,1
106,22q11.2 copy number variation syndrome WP4657,0.205072018694388,2.4407407407407407,3.8670951092591515,"['ACTA2', 'HES1']",0.373266403011594,0,0,2
107,EGF/EGFR signaling pathway WP437,0.20958640686852661,1.9421641791044777,3.0348629996282273,"['PLSCR1', 'EGF', 'PLCE1']",0.373266403011594,0,0,3
108,Sphingolipid Metabolism (integrated pathway) WP4726,0.21329508743519654,4.380147058823529,6.76767185782465,['UGCG'],0.373266403011594,0,0,1
109,TLR4 Signaling and Tolerance WP3851,0.21329508743519654,4.380147058823529,6.76767185782465,['IRF7'],0.373266403011594,0,0,1
110,Tryptophan metabolism WP465,0.21329508743519654,4.380147058823529,6.76767185782465,['HAAO'],0.373266403011594,0,0,1
111,Type II interferon signaling (IFNG) WP619,0.21329508743519654,4.380147058823529,6.76767185782465,['SOCS3'],0.373266403011594,0,0,1
112,Wnt signaling in kidney disease WP4150,0.21329508743519654,4.380147058823529,6.76767185782465,['WNT7B'],0.373266403011594,0,0,1
113,EPO Receptor Signaling WP581,0.21329508743519654,4.380147058823529,6.76767185782465,['IRS2'],0.373266403011594,0,0,1
114,miRNAs involvement in the immune response in sepsis WP4329,0.21329508743519654,4.380147058823529,6.76767185782465,['IRF7'],0.373266403011594,0,0,1
115,Pre-implantation embryo WP3527,0.21329508743519654,4.380147058823529,6.76767185782465,['ZFP36'],0.373266403011594,0,0,1
116,SARS-CoV-2 mitochondrial interactions WP5038,0.21329508743519654,4.380147058823529,6.76767185782465,['IRF7'],0.373266403011594,0,0,1
117,Aryl Hydrocarbon Receptor Pathway WP2873,0.22223935451595037,4.171218487394958,6.273513874870164,['HES1'],0.37595490805614934,0,0,1
118,Vitamin A and carotenoid metabolism WP716,0.22223935451595037,4.171218487394958,6.273513874870164,['RBP2'],0.37595490805614934,0,0,1
119,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.22223935451595037,4.171218487394958,6.273513874870164,['NOD1'],0.37595490805614934,0,0,1
120,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.22223935451595037,4.171218487394958,6.273513874870164,['NDRG1'],0.37595490805614934,0,0,1
121,DNA damage response (only ATM dependent) WP710,0.22591642253156127,2.2812890812890814,3.393623189245689,"['BCL6', 'WNT7B']",0.37901680804881765,0,0,2
122,Oxidation by Cytochrome P450 WP43,0.23108266558128054,3.981283422459893,5.832499683757836,['CYP39A1'],0.38450640256557334,0,0,1
123,Sphingolipid pathway WP1422,0.23982615183657818,3.807864450127877,5.437024929001156,['UGCG'],0.389477670582603,0,0,1
124,Neovascularisation processes WP4331,0.23982615183657818,3.807864450127877,5.437024929001156,['SMAD9'],0.389477670582603,0,0,1
125,Oxysterols derived from cholesterol WP4545,0.23982615183657818,3.807864450127877,5.437024929001156,['CYP39A1'],0.389477670582603,0,0,1
126,Resistin as a regulator of inflammation WP4481,0.24847093188028102,3.6488970588235294,5.080831595598221,['PLCE1'],0.40031427914045276,0,0,1
127,Gastrin signaling pathway WP4659,0.25533085796585525,2.0899470899470898,2.8531855110047712,"['PRKCQ', 'CD44']",0.40445485833458583,0,0,2
128,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.25701811194660873,3.5026470588235292,4.758726844449447,['PRKCQ'],0.40445485833458583,0,0,1
129,Oxidative Damage WP3941,0.25701811194660873,3.5026470588235292,4.758726844449447,['C1R'],0.40445485833458583,0,0,1
130,Alpha 6 Beta 4 signaling pathway WP244,0.27382403550256085,3.2426470588235294,4.200102110481594,['IRS2'],0.42110817581075644,0,0,1
131,Bladder cancer WP2828,0.27382403550256085,3.2426470588235294,4.200102110481594,['EGF'],0.42110817581075644,0,0,1
132,Folate Metabolism WP176,0.27382403550256085,3.2426470588235294,4.200102110481594,['SERPINA3'],0.42110817581075644,0,0,1
133,Ebola Virus Pathway on Host WP4217,0.28061299429754377,1.9496296296296296,2.477548007841224,"['SOCS3', 'IRF7']",0.42830404392783,0,0,2
134,Aryl Hydrocarbon Receptor Netpath WP2586,0.2902525283397218,3.018509127789047,3.7339077067564728,['KLF6'],0.4397109197982353,0,0,1
135,Signaling of Hepatocyte Growth Factor Receptor WP313,0.2983278753921517,2.9176470588235293,3.529075432832682,['HGF'],0.4429430998207738,0,0,1
136,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.2983278753921517,2.9176470588235293,3.529075432832682,['MAP3K14'],0.4429430998207738,0,0,1
137,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.30583500044950007,1.826851851851852,2.1642888109818994,"['HES1', 'HES5']",0.4429430998207738,0,0,2
138,Hepatitis C and Hepatocellular Carcinoma WP3646,0.30631200590320423,2.823292220113852,3.3403812093484713,['CD44'],0.4429430998207738,0,0,1
139,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.30631200590320423,2.823292220113852,3.3403812093484713,['IFITM3'],0.4429430998207738,0,0,1
140,p38 MAPK Signaling Pathway WP400,0.30631200590320423,2.823292220113852,3.3403812093484713,['HSPB1'],0.4429430998207738,0,0,1
141,Fas ligand pathway and stress induction of heat shock proteins WP314,0.314205942730007,2.7348345588235294,3.16613612666976,['HSPB1'],0.4429430998207738,0,0,1
142,Ferroptosis WP4313,0.314205942730007,2.7348345588235294,3.16613612666976,['CP'],0.4429430998207738,0,0,1
143,IL-2 signaling pathway WP49,0.314205942730007,2.7348345588235294,3.16613612666976,['SOCS3'],0.4429430998207738,0,0,1
144,Phosphoinositides metabolism WP4971,0.314205942730007,2.7348345588235294,3.16613612666976,['PLCE1'],0.4429430998207738,0,0,1
145,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.32201069733556825,2.6517379679144386,3.004871271986105,['ACTA2'],0.44772720245972847,0,0,1
146,Nephrotic syndrome WP4758,0.32201069733556825,2.6517379679144386,3.004871271986105,['PLCE1'],0.44772720245972847,0,0,1
147,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3297272699813244,2.573529411764706,2.8553036565363255,['IRF7'],0.45533765854563846,0,0,1
148,IL-6 signaling pathway WP364,0.33735664963731576,2.4997899159663866,2.7163082214048693,['SOCS3'],0.4627256748403723,0,0,1
149,Interleukin-11 Signaling Pathway WP2332,0.34489981447818996,2.4301470588235294,2.5868946958720302,['SOCS3'],0.46750731713059596,0,0,1
150,Endochondral Ossification with Skeletal Dysplasias WP4808,0.3523577316304492,2.364268680445151,2.466188370083006,['SLC38A2'],0.46750731713059596,0,0,1
151,Endochondral Ossification WP474,0.3523577316304492,2.364268680445151,2.466188370083006,['SLC38A2'],0.46750731713059596,0,0,1
152,Glycogen Synthesis and Degradation WP500,0.3523577316304492,2.364268680445151,2.466188370083006,['HKDC1'],0.46750731713059596,0,0,1
153,IL-3 signaling pathway WP286,0.3523577316304492,2.364268680445151,2.466188370083006,['ENPP3'],0.46750731713059596,0,0,1
154,ATM Signaling Network in Development and Disease  WP3878,0.3597313574860225,2.301857585139319,2.3534140280784124,['HSPB1'],0.4741913348679387,0,0,1
155,Cytosolic DNA-sensing pathway WP4655,0.36702163784191133,2.2426470588235294,2.24788246000234,['IRF7'],0.4806799514961806,0,0,1
156,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.37422950785431724,2.1863970588235295,2.1489790867003347,['SYNE2'],0.4823190682949114,0,0,1
157,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.37422950785431724,2.1863970588235295,2.1489790867003347,['CP'],0.4823190682949114,0,0,1
158,PI3K-Akt signaling pathway WP4172,0.37540104822953696,1.3838177533385703,1.3558097836910359,"['EGF', 'HGF', 'OSMR']",0.4823190682949114,0,0,3
159,Integrated breast cancer pathway WP1984,0.3882609184411696,1.5093231162196679,1.4279369350394366,"['ITPKC', 'RASGEF1A']",0.4897238900115292,0,0,2
160,Synaptic Vesicle Pathway WP2267,0.3884017058712128,2.081932773109244,1.9689153659085306,['SLC22A3'],0.4897238900115292,0,0,1
161,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3884017058712128,2.081932773109244,1.9689153659085306,['IRF7'],0.4897238900115292,0,0,1
162,Selenium Micronutrient Network WP15,0.3953678526804135,2.033344733242134,1.8868192172528735,['SERPINA3'],0.4923906386142573,0,0,1
163,RANKL/RANK signaling pathway WP2018,0.3953678526804135,2.033344733242134,1.8868192172528735,['TNFRSF11B'],0.4923906386142573,0,0,1
164,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.4022552270569757,1.9869652406417113,1.8094666525569094,['WNT7B'],0.4979134822717443,0,0,1
165,Nonalcoholic fatty liver disease WP4396,0.4161531768105706,1.422583559168925,1.2471816708336056,"['SOCS3', 'IRS2']",0.5119945145002778,0,0,2
166,Rett syndrome causing genes WP4312,0.42245350889782085,1.859668335419274,1.6024313426450032,['SYNE2'],0.5166148331702267,0,0,1
167,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.44197408711074393,1.7476470588235293,1.4269608579299649,['PLCE1'],0.5372499382244372,0,0,1
168,Apoptosis WP254,0.45462248398687777,1.6801470588235294,1.3244396134097676,['IRF7'],0.5460849955582022,0,0,1
169,MET in type 1 papillary renal cell carcinoma WP4205,0.45462248398687777,1.6801470588235294,1.3244396134097676,['HGF'],0.5460849955582022,0,0,1
170,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.4608395386286024,1.64830743618202,1.2769526205166153,['WNT7B'],0.5502966255388605,0,0,1
171,Focal Adhesion WP306,0.46619859449292345,1.2851851851851852,0.9807808067357386,"['EGF', 'HGF']",0.5534404367372132,0,0,2
172,Toll-like Receptor Signaling Pathway WP75,0.4730633574542837,1.588101604278075,1.1887352641892863,['IRF7'],0.5583247765303465,0,0,1
173,Endometrial cancer WP4155,0.4850120149626897,1.5321207430340558,1.108614401975884,['EGF'],0.5691181447250059,0,0,1
174,Non-small cell lung cancer WP4255,0.5081083074323984,1.4311716489874637,0.9689900076709947,['EGF'],0.5925291437263756,0,0,1
175,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5137198487479907,1.4079696394686907,0.9378164800171592,['PRKCQ'],0.5925291437263756,0,0,1
176,DNA IR-damage and cellular response via ATR WP4016,0.5137198487479907,1.4079696394686907,0.9378164800171592,['BCL6'],0.5925291437263756,0,0,1
177,Leptin signaling pathway WP2034,0.5301759921007263,1.3426470588235293,0.851971679059519,['SOCS3'],0.6080549513923584,0,0,1
178,Pathways Regulating Hippo Signaling WP4540,0.5355375685015257,1.322192513368984,0.825688381058025,['PRKCQ'],0.6099455294540395,0,0,1
179,Corticotropin-releasing hormone signaling pathway WP2355,0.5408384005011188,1.3023485513608428,0.8004686761879745,['PRKCQ'],0.6099455294540395,0,0,1
180,Glioblastoma signaling pathways WP2261,0.5408384005011188,1.3023485513608428,0.8004686761879745,['PRKCQ'],0.6099455294540395,0,0,1
181,B Cell Receptor Signaling Pathway WP23,0.5460791714044256,1.2830882352941178,0.7762572338262184,['BCL6'],0.6115076121302141,0,0,1
182,Hippo-Merlin Signaling Dysregulation WP4541,0.5512605567479271,1.264386189258312,0.7530022892526894,['CD44'],0.6115076121302141,0,0,1
183,Pathways in clear cell renal cell carcinoma WP4018,0.5512605567479271,1.264386189258312,0.7530022892526894,['ENPP3'],0.6115076121302141,0,0,1
184,Pyrimidine metabolism WP4022,0.5614478354129777,1.228562551781276,0.7091710384752936,['ENPP3'],0.6194234271132308,0,0,1
185,Pancreatic adenocarcinoma pathway WP4263,0.5664550425172188,1.2113970588235294,0.6885066786504609,['EGF'],0.6215695871945698,0,0,1
186,TNF-alpha signaling pathway WP231,0.5762998218118208,1.1784578696343402,0.6494802210486311,['MAP3K14'],0.6241859727335721,0,0,1
187,Wnt signaling WP428,0.5762998218118208,1.1784578696343402,0.6494802210486311,['WNT7B'],0.6241859727335721,0,0,1
188,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5807680841937635,0.9866876823787514,0.53616980487642,"['HSPB1', 'NDRG1', 'APOLD1', 'HSPA1A']",0.6241859727335721,0,0,4
189,G Protein Signaling Pathways WP35,0.5811386642691878,1.1626470588235294,0.631045160721466,['PRKCQ'],0.6241859727335721,0,0,1
190,ErbB signaling pathway WP673,0.5953284760165655,1.1176470588235294,0.5796586670260333,['EGF'],0.6360614770071725,0,0,1
191,Regulation of toll-like receptor signaling pathway WP1449,0.5999515434831376,1.1034065524944154,0.5637374561077134,['IRF7'],0.6376448341731777,0,0,1
192,Cytoplasmic Ribosomal Proteins WP477,0.6266092652086763,1.025,0.47911791694519434,['RPS4Y1'],0.6625087543612568,0,0,1
193,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6633243729864862,0.9261576971214017,0.3801795456593273,['WNT7B'],0.6976935114831953,0,0,1
194,Chemokine signaling pathway WP3929,0.6747478475065486,0.8972862340812614,0.3530069559128421,['GRK5'],0.7024298104811763,0,0,1
195,Mesodermal commitment pathway WP2857,0.6747478475065486,0.8972862340812614,0.3530069559128421,['HMGA2'],0.7024298104811763,0,0,1
196,TGF-beta Signaling Pathway WP366,0.7033636367029136,0.8283613445378152,0.2914848309580004,['KLF6'],0.7247858794451344,0,0,1
197,Ectoderm Differentiation WP2858,0.7033636367029136,0.8283613445378152,0.2914848309580004,['TNFRSF11B'],0.7247858794451344,0,0,1
198,Regulation of Actin Cytoskeleton WP51,0.7199643194415644,0.7903743315508022,0.2596803513674027,['EGF'],0.7381452365991796,0,0,1
199,Hepatitis B infection WP4666,0.7356423737603839,0.7556905370843989,0.23200544619561955,['IRF7'],0.7504291551425022,0,0,1
200,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7671332646651337,0.6890756302521008,0.18267032833140442,['IRS2'],0.7747664314777221,0,0,1
201,Circadian rhythm related genes WP3594,0.7671332646651337,0.6890756302521008,0.18267032833140442,['ID3'],0.7747664314777221,0,0,1
202,Ras signaling WP4223,0.777636177525629,0.6676470588235294,0.16791090007997325,['PLCE1'],0.7814858615727855,0,0,1
203,Ciliary landscape WP4352,0.897592325970794,0.4380785309047477,0.047329695085123864,['CDH23'],0.897592325970794,0,0,1
